Ni Jie, Liu Siwen, Qi Feng, Li Xiao, Yu Shaorong, Feng Jifeng, Zheng Yuxiao
Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Research Center for Clinical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
Ann Transl Med. 2020 Mar;8(5):209. doi: 10.21037/atm.2020.01.73.
To identify prognostic hub genes which associated with tumor microenvironment (TME) in lower grade glioma (LGG) of central nervous system.
We downloaded LGG patients gene transcriptome profiles of the central nervous system in The Cancer Genome Atlas (TCGA) database. Clinical characteristics and survival data through the Genomic Data Commons (GDC) tool were extracted. We used limma package for normalization processing. Scores of immune, stromal and ESTIMATE were calculated using ESTIMATE algorithm. Then, box plots were applied to explore the association between immune scores, stromal scores, ESTIMATE scores and histological type, tumor grade. Kaplan-Meier (K-M) analysis was utilized to explore the prognostic value of scores. Furthermore, heatmaps and volcano plots were applied for visualizing expression of differential expressed-gene screening and cluster analysis. Venn plots were constructed to screen the intersected differentially expressed genes (DEGs). In addition, enrichment of functions and signaling pathways and Gene Set Enrichment Analysis (GESA) of the DEGs were performed. Then we used protein-protein interaction (PPI) network and Cytoscape software to identify hub genes. We evaluated the prognostic value of hub genes and risk score (RS) calculated based on multivariate cox regression analysis. Finally, relationships of hub genes with the TME of LGG patients were evaluated based on tumor immune estimation resource (TIMER) database.
Gene expression profiles and clinical data of 514 LGG samples were extracted and the results revealed that higher scores were significantly related with histological types and higher tumor grade (P<0.0001, respectively). Besides, higher scores were associated with worse survival outcomes in immune scores (P=0.0167), stromal scores (P=0.0035) and ESTIMATE scores (P=0.0190). Then, 785 up-regulated intersected genes and 357 down-regulated intersected genes were revealed. Functional enrichment analysis revealed that intersected genes were associated with immune response, inflammatory response, plasma membrane and receptor activity. After PPI network construction and cytoHubba analysis, 25 tumor immune-related hub genes were identified and enriched pathways were identified by GSEA. Besides, receiver operating characteristic (ROC) curves showed significantly predictive accuracy [area under curve (AUC) =0.771] of RS. Furthermore, significant prognostic values of hub genes were observed, and the relationships between hub genes and LGG TME were demonstrated.
We identified 25 TME-related genes which significantly associated with overall survival in patients with central nervous system LGG from TCGA database.
识别与中枢神经系统低级别胶质瘤(LGG)肿瘤微环境(TME)相关的预后关键基因。
我们从癌症基因组图谱(TCGA)数据库下载了中枢神经系统LGG患者的基因转录组图谱。通过基因组数据共享(GDC)工具提取临床特征和生存数据。我们使用limma软件包进行标准化处理。使用ESTIMATE算法计算免疫、基质和ESTIMATE评分。然后,应用箱线图探讨免疫评分、基质评分、ESTIMATE评分与组织学类型、肿瘤分级之间的关联。采用Kaplan-Meier(K-M)分析探讨评分的预后价值。此外,应用热图和火山图对差异表达基因筛选和聚类分析的表达进行可视化。构建维恩图以筛选交集差异表达基因(DEG)。此外还对DEG进行了功能和信号通路富集以及基因集富集分析(GESA)。然后我们使用蛋白质-蛋白质相互作用(PPI)网络和Cytoscape软件来识别关键基因。我们基于多变量cox回归分析评估关键基因的预后价值和风险评分(RS)。最后,基于肿瘤免疫评估资源(TIMER)数据库评估关键基因与LGG患者TME的关系。
提取了514个LGG样本的基因表达谱和临床数据,结果显示较高的评分分别与组织学类型和较高的肿瘤分级显著相关(P<0.0001)。此外,免疫评分(P=0.0167)、基质评分(P=0.0035)和ESTIMATE评分(P=0.0190)较高与较差的生存结果相关。然后,揭示了785个上调交集基因和357个下调交集基因。功能富集分析表明,交集基因与免疫反应、炎症反应、质膜和受体活性相关。构建PPI网络并进行cytoHubba分析后,鉴定出25个肿瘤免疫相关关键基因,并通过GSEA鉴定了富集通路。此外,受试者工作特征(ROC)曲线显示RS具有显著的预测准确性[曲线下面积(AUC)=0.771]。此外,观察到关键基因具有显著的预后价值,并证明了关键基因与LGG TME之间的关系。
我们从TCGA数据库中鉴定出25个与中枢神经系统LGG患者总生存显著相关的TME相关基因。